Serum interleukin-6 levels correlate with the severity of dementia in down syndrome and in Alzheimer's disease

J. Kálmán, A. Juhász, G. Laird, P. Dickens, T. Járdánházy, A. Rimanóczy, I. Boncz, W. L I Parry-Jones, Z. Janka

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

Introduction - Inflammatory processes are suspected in the pathomechanism of Alzheimer's dementia (AD) but the serum and cerebrospinal fluid (CSF) levels of inflammatory cytokines are not yet determined in the different forms of the disorder. Subjects and methods - Interleukin-6 (IL-6) levels were examined in the sera and CSF of patients with mild-moderate and severe stage of late onset sporadic type of AD and in the sera of demented Down syndrome (DS) probands with similar stages of AD and compared with data of age-matched healthy controls. Results - Normal serum IL-6 levels were found in the mild-moderate stage, but significantly increased levels were found in the severe stage of both dementia groups. The CSF concentrations remained within the normal range in all groups. Positive correlations between the serum IL-6 levels and age and the severity of the disease were present. Conclusion - These findings suggest a disease stage dependent general activation of the immune system both in sporadic AD and in DS with AD.

Original languageEnglish
Pages (from-to)236-240
Number of pages5
JournalActa Neurologica Scandinavica
Volume96
Issue number4
Publication statusPublished - 1997

Fingerprint

Down Syndrome
Dementia
Interleukin-6
Alzheimer Disease
Cerebrospinal Fluid
Serum
Immune System
Reference Values
Cytokines

Keywords

  • Alzheimer's disease
  • Cerebrospinal fluid
  • Dementia
  • Down syndrome
  • Interleukin- 6
  • Serum

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Serum interleukin-6 levels correlate with the severity of dementia in down syndrome and in Alzheimer's disease. / Kálmán, J.; Juhász, A.; Laird, G.; Dickens, P.; Járdánházy, T.; Rimanóczy, A.; Boncz, I.; Parry-Jones, W. L I; Janka, Z.

In: Acta Neurologica Scandinavica, Vol. 96, No. 4, 1997, p. 236-240.

Research output: Contribution to journalArticle

@article{6c541c97a8304cf9bb3f839770cedb67,
title = "Serum interleukin-6 levels correlate with the severity of dementia in down syndrome and in Alzheimer's disease",
abstract = "Introduction - Inflammatory processes are suspected in the pathomechanism of Alzheimer's dementia (AD) but the serum and cerebrospinal fluid (CSF) levels of inflammatory cytokines are not yet determined in the different forms of the disorder. Subjects and methods - Interleukin-6 (IL-6) levels were examined in the sera and CSF of patients with mild-moderate and severe stage of late onset sporadic type of AD and in the sera of demented Down syndrome (DS) probands with similar stages of AD and compared with data of age-matched healthy controls. Results - Normal serum IL-6 levels were found in the mild-moderate stage, but significantly increased levels were found in the severe stage of both dementia groups. The CSF concentrations remained within the normal range in all groups. Positive correlations between the serum IL-6 levels and age and the severity of the disease were present. Conclusion - These findings suggest a disease stage dependent general activation of the immune system both in sporadic AD and in DS with AD.",
keywords = "Alzheimer's disease, Cerebrospinal fluid, Dementia, Down syndrome, Interleukin- 6, Serum",
author = "J. K{\'a}lm{\'a}n and A. Juh{\'a}sz and G. Laird and P. Dickens and T. J{\'a}rd{\'a}nh{\'a}zy and A. Riman{\'o}czy and I. Boncz and Parry-Jones, {W. L I} and Z. Janka",
year = "1997",
language = "English",
volume = "96",
pages = "236--240",
journal = "Acta Neurologica Scandinavica",
issn = "0001-6314",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Serum interleukin-6 levels correlate with the severity of dementia in down syndrome and in Alzheimer's disease

AU - Kálmán, J.

AU - Juhász, A.

AU - Laird, G.

AU - Dickens, P.

AU - Járdánházy, T.

AU - Rimanóczy, A.

AU - Boncz, I.

AU - Parry-Jones, W. L I

AU - Janka, Z.

PY - 1997

Y1 - 1997

N2 - Introduction - Inflammatory processes are suspected in the pathomechanism of Alzheimer's dementia (AD) but the serum and cerebrospinal fluid (CSF) levels of inflammatory cytokines are not yet determined in the different forms of the disorder. Subjects and methods - Interleukin-6 (IL-6) levels were examined in the sera and CSF of patients with mild-moderate and severe stage of late onset sporadic type of AD and in the sera of demented Down syndrome (DS) probands with similar stages of AD and compared with data of age-matched healthy controls. Results - Normal serum IL-6 levels were found in the mild-moderate stage, but significantly increased levels were found in the severe stage of both dementia groups. The CSF concentrations remained within the normal range in all groups. Positive correlations between the serum IL-6 levels and age and the severity of the disease were present. Conclusion - These findings suggest a disease stage dependent general activation of the immune system both in sporadic AD and in DS with AD.

AB - Introduction - Inflammatory processes are suspected in the pathomechanism of Alzheimer's dementia (AD) but the serum and cerebrospinal fluid (CSF) levels of inflammatory cytokines are not yet determined in the different forms of the disorder. Subjects and methods - Interleukin-6 (IL-6) levels were examined in the sera and CSF of patients with mild-moderate and severe stage of late onset sporadic type of AD and in the sera of demented Down syndrome (DS) probands with similar stages of AD and compared with data of age-matched healthy controls. Results - Normal serum IL-6 levels were found in the mild-moderate stage, but significantly increased levels were found in the severe stage of both dementia groups. The CSF concentrations remained within the normal range in all groups. Positive correlations between the serum IL-6 levels and age and the severity of the disease were present. Conclusion - These findings suggest a disease stage dependent general activation of the immune system both in sporadic AD and in DS with AD.

KW - Alzheimer's disease

KW - Cerebrospinal fluid

KW - Dementia

KW - Down syndrome

KW - Interleukin- 6

KW - Serum

UR - http://www.scopus.com/inward/record.url?scp=0030855888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030855888&partnerID=8YFLogxK

M3 - Article

VL - 96

SP - 236

EP - 240

JO - Acta Neurologica Scandinavica

JF - Acta Neurologica Scandinavica

SN - 0001-6314

IS - 4

ER -